In-stent restenosis after carotid angioplasty-stenting

Incidence and management

Elie Y. Chakhtoura, Robert W. Hobson, Jonathan Goldstein, Gregory T. Simonian, Brajesh K. Lal, Paul B. Haser, Michael Silva, Frank T. Padberg, Peter J. Pappas, Zafar Jamil

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Purpose: Carotid angioplasty-stenting (CAS) has been advocated as an alternative to carotid endarterectomy (CEA) in patients with restenotic lesions after prior CEA, primary stenoses with significant medical comorbidities, and radiation-induced stenoses. The incidence of restenosis after CAS and its management remains ill defined. We evaluated the incidence and management of in-stent restenosis after CAS. Methods: Patients with asymptomatic (61%) and symptomatic (39%) carotid stenosis of ≥ 80% underwent CAS between September 1996 and May 2000; there were 50 procedures and 46 patients (26 men and 20 women). All patients were followed up clinically and underwent duplex ultrasonography (DU) at 3- to 6-month intervals. In-stent restenoses ≥ 80% detected with DU were further evaluated by means of angiography for confirmation of the severity of stenosis. Results: No periprocedural or late strokes occurred in the 50 CAS procedures during the 30-day follow-up period. One death (2.2%) that resulted from myocardial infarction was observed 10 days after discharge following CAS. During a mean follow-up period of 18 ± 10 months (range, 1-44 months), in-stent restenosis was observed after four (8%) of the 50 CAS procedures. Angiography confirmed these high-grade (≥ 80%) in-stent restenoses, which were successfully treated with balloon angioplasty (3) or angioplasty and restenting (1). No periprocedural complications occurred, and these patients remained asymptomatic and without recurrent restenosis over a mean follow-up time of 10 ± 6 months. Conclusions: We recommend CAS for post-CEA restenosis, primary stenoses in patients with high-risk medical comorbidities, and radiation-induced stenoses. In-stent restenoses occurred after 8% of CAS procedures and were managed without complications with repeat angioplasty or repeat angioplasty and restenting.

Original languageEnglish (US)
Pages (from-to)220-226
Number of pages7
JournalJournal of Vascular Surgery
Volume33
Issue number2
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Angioplasty
Stents
Incidence
Pathologic Constriction
Carotid Endarterectomy
Comorbidity
Ultrasonography
Angiography
Radiation
Balloon Angioplasty
Carotid Stenosis
Stroke
Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Chakhtoura, E. Y., Hobson, R. W., Goldstein, J., Simonian, G. T., Lal, B. K., Haser, P. B., ... Jamil, Z. (2001). In-stent restenosis after carotid angioplasty-stenting: Incidence and management. Journal of Vascular Surgery, 33(2), 220-226. https://doi.org/10.1067/mva.2001.111880

In-stent restenosis after carotid angioplasty-stenting : Incidence and management. / Chakhtoura, Elie Y.; Hobson, Robert W.; Goldstein, Jonathan; Simonian, Gregory T.; Lal, Brajesh K.; Haser, Paul B.; Silva, Michael; Padberg, Frank T.; Pappas, Peter J.; Jamil, Zafar.

In: Journal of Vascular Surgery, Vol. 33, No. 2, 2001, p. 220-226.

Research output: Contribution to journalArticle

Chakhtoura, EY, Hobson, RW, Goldstein, J, Simonian, GT, Lal, BK, Haser, PB, Silva, M, Padberg, FT, Pappas, PJ & Jamil, Z 2001, 'In-stent restenosis after carotid angioplasty-stenting: Incidence and management', Journal of Vascular Surgery, vol. 33, no. 2, pp. 220-226. https://doi.org/10.1067/mva.2001.111880
Chakhtoura EY, Hobson RW, Goldstein J, Simonian GT, Lal BK, Haser PB et al. In-stent restenosis after carotid angioplasty-stenting: Incidence and management. Journal of Vascular Surgery. 2001;33(2):220-226. https://doi.org/10.1067/mva.2001.111880
Chakhtoura, Elie Y. ; Hobson, Robert W. ; Goldstein, Jonathan ; Simonian, Gregory T. ; Lal, Brajesh K. ; Haser, Paul B. ; Silva, Michael ; Padberg, Frank T. ; Pappas, Peter J. ; Jamil, Zafar. / In-stent restenosis after carotid angioplasty-stenting : Incidence and management. In: Journal of Vascular Surgery. 2001 ; Vol. 33, No. 2. pp. 220-226.
@article{7dda5bd3576b4bf6a2675fac136b8a5c,
title = "In-stent restenosis after carotid angioplasty-stenting: Incidence and management",
abstract = "Purpose: Carotid angioplasty-stenting (CAS) has been advocated as an alternative to carotid endarterectomy (CEA) in patients with restenotic lesions after prior CEA, primary stenoses with significant medical comorbidities, and radiation-induced stenoses. The incidence of restenosis after CAS and its management remains ill defined. We evaluated the incidence and management of in-stent restenosis after CAS. Methods: Patients with asymptomatic (61{\%}) and symptomatic (39{\%}) carotid stenosis of ≥ 80{\%} underwent CAS between September 1996 and May 2000; there were 50 procedures and 46 patients (26 men and 20 women). All patients were followed up clinically and underwent duplex ultrasonography (DU) at 3- to 6-month intervals. In-stent restenoses ≥ 80{\%} detected with DU were further evaluated by means of angiography for confirmation of the severity of stenosis. Results: No periprocedural or late strokes occurred in the 50 CAS procedures during the 30-day follow-up period. One death (2.2{\%}) that resulted from myocardial infarction was observed 10 days after discharge following CAS. During a mean follow-up period of 18 ± 10 months (range, 1-44 months), in-stent restenosis was observed after four (8{\%}) of the 50 CAS procedures. Angiography confirmed these high-grade (≥ 80{\%}) in-stent restenoses, which were successfully treated with balloon angioplasty (3) or angioplasty and restenting (1). No periprocedural complications occurred, and these patients remained asymptomatic and without recurrent restenosis over a mean follow-up time of 10 ± 6 months. Conclusions: We recommend CAS for post-CEA restenosis, primary stenoses in patients with high-risk medical comorbidities, and radiation-induced stenoses. In-stent restenoses occurred after 8{\%} of CAS procedures and were managed without complications with repeat angioplasty or repeat angioplasty and restenting.",
author = "Chakhtoura, {Elie Y.} and Hobson, {Robert W.} and Jonathan Goldstein and Simonian, {Gregory T.} and Lal, {Brajesh K.} and Haser, {Paul B.} and Michael Silva and Padberg, {Frank T.} and Pappas, {Peter J.} and Zafar Jamil",
year = "2001",
doi = "10.1067/mva.2001.111880",
language = "English (US)",
volume = "33",
pages = "220--226",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - In-stent restenosis after carotid angioplasty-stenting

T2 - Incidence and management

AU - Chakhtoura, Elie Y.

AU - Hobson, Robert W.

AU - Goldstein, Jonathan

AU - Simonian, Gregory T.

AU - Lal, Brajesh K.

AU - Haser, Paul B.

AU - Silva, Michael

AU - Padberg, Frank T.

AU - Pappas, Peter J.

AU - Jamil, Zafar

PY - 2001

Y1 - 2001

N2 - Purpose: Carotid angioplasty-stenting (CAS) has been advocated as an alternative to carotid endarterectomy (CEA) in patients with restenotic lesions after prior CEA, primary stenoses with significant medical comorbidities, and radiation-induced stenoses. The incidence of restenosis after CAS and its management remains ill defined. We evaluated the incidence and management of in-stent restenosis after CAS. Methods: Patients with asymptomatic (61%) and symptomatic (39%) carotid stenosis of ≥ 80% underwent CAS between September 1996 and May 2000; there were 50 procedures and 46 patients (26 men and 20 women). All patients were followed up clinically and underwent duplex ultrasonography (DU) at 3- to 6-month intervals. In-stent restenoses ≥ 80% detected with DU were further evaluated by means of angiography for confirmation of the severity of stenosis. Results: No periprocedural or late strokes occurred in the 50 CAS procedures during the 30-day follow-up period. One death (2.2%) that resulted from myocardial infarction was observed 10 days after discharge following CAS. During a mean follow-up period of 18 ± 10 months (range, 1-44 months), in-stent restenosis was observed after four (8%) of the 50 CAS procedures. Angiography confirmed these high-grade (≥ 80%) in-stent restenoses, which were successfully treated with balloon angioplasty (3) or angioplasty and restenting (1). No periprocedural complications occurred, and these patients remained asymptomatic and without recurrent restenosis over a mean follow-up time of 10 ± 6 months. Conclusions: We recommend CAS for post-CEA restenosis, primary stenoses in patients with high-risk medical comorbidities, and radiation-induced stenoses. In-stent restenoses occurred after 8% of CAS procedures and were managed without complications with repeat angioplasty or repeat angioplasty and restenting.

AB - Purpose: Carotid angioplasty-stenting (CAS) has been advocated as an alternative to carotid endarterectomy (CEA) in patients with restenotic lesions after prior CEA, primary stenoses with significant medical comorbidities, and radiation-induced stenoses. The incidence of restenosis after CAS and its management remains ill defined. We evaluated the incidence and management of in-stent restenosis after CAS. Methods: Patients with asymptomatic (61%) and symptomatic (39%) carotid stenosis of ≥ 80% underwent CAS between September 1996 and May 2000; there were 50 procedures and 46 patients (26 men and 20 women). All patients were followed up clinically and underwent duplex ultrasonography (DU) at 3- to 6-month intervals. In-stent restenoses ≥ 80% detected with DU were further evaluated by means of angiography for confirmation of the severity of stenosis. Results: No periprocedural or late strokes occurred in the 50 CAS procedures during the 30-day follow-up period. One death (2.2%) that resulted from myocardial infarction was observed 10 days after discharge following CAS. During a mean follow-up period of 18 ± 10 months (range, 1-44 months), in-stent restenosis was observed after four (8%) of the 50 CAS procedures. Angiography confirmed these high-grade (≥ 80%) in-stent restenoses, which were successfully treated with balloon angioplasty (3) or angioplasty and restenting (1). No periprocedural complications occurred, and these patients remained asymptomatic and without recurrent restenosis over a mean follow-up time of 10 ± 6 months. Conclusions: We recommend CAS for post-CEA restenosis, primary stenoses in patients with high-risk medical comorbidities, and radiation-induced stenoses. In-stent restenoses occurred after 8% of CAS procedures and were managed without complications with repeat angioplasty or repeat angioplasty and restenting.

UR - http://www.scopus.com/inward/record.url?scp=0035105492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035105492&partnerID=8YFLogxK

U2 - 10.1067/mva.2001.111880

DO - 10.1067/mva.2001.111880

M3 - Article

VL - 33

SP - 220

EP - 226

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 2

ER -